The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to ...

Natco Pharma updates on Risdiplam launch in India, Delhi High Court denies Roche's injunction plea, pricing set at ₹15,900.

Natco Pharma plans to launch generic Risdiplam pending Delhi High Court decision, offering discounts to patients.

India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...

With an overview of the Nifty 50 to Donald Trump's tariff, Experts recommend eight stocks to buy or sell on Wednesday — 9 ...

India’s benchmark indices bounced back strongly on Tuesday, recouping overnight losses to end over 1.5% higher. The Sensex ...